Medtronic (NYSE:MDT) must pay $106.5 million in a TAVI patent infringement lawsuit, a federal jury in California ruled this week. Colibri Heart Valve claimed in 2019 that Medtronic violated its patents for replacement heart valves. The lawsuit alleged infringement of two patents with the Medtronic CoreValve, CoreValve Evolut R, CoreValve Evolut Pro, and CoreValve Evolut […]
CoreValve Inc.
Appeals court upholds Medtronic’s win in patent spat with doc inventor
A federal appeals court yesterday upheld a win for Medtronic (NYSE:MDT) in a patent dispute over its CoreValve aortic valve replacement with inventor Dr. Troy Norred, according to legal filings. The physician’s 2013 patent infringement lawsuit, filed in the U.S. District Court for Kansas, was stayed until a trio of inter partes reviews by the U.S. Patent & Trademark Office’s […]
TAVI: Study finds low stroke rates with Medtronic’s CoreValve
A clinical study of nearly 1,000 patients implanted with Medtronic‘s (NYSE:MDT) CoreValve replacement heart valve found a low rate of stroke out to 2 years. The study, published last month in the Journal of the American College of Cardiology, evaluated patients for neurological events over 3 periods after the procedure to implant the CoreValve transcatheter aortic […]
Medtronic reports positive CoreValve data
Appeals court puts hold on ban of Medtronic’s CoreValve device | Medtech legal news for the week of Apr. 28, 2014
Appeals court stays ban on Medtronic’s CoreValve device
Edwards Lifesciences decries Medtronic’s ‘scare tactics’ in CoreValve dispute
UPDATED April 21, 2014, at 12:30 p.m. with comment from Medtronic.
UPDATED April 21, 2014, at 3:45 p.m. with comment from Edwards Lifesciences.
Medtronic asks Supreme Court to overturn $74M loss against Edwards Lifesciences
Edwards Lifesciences wants more from Medtronic over CoreValve infringement
Appeals court upholds $74M Edwards Lifesciences win over Medtronic
UPDATED Nov. 13, 2012, 5:30 p.m. with comment from Medtronic
UPDATED Nov. 13, 2012, 2:30 p.m. with comment from Edwards Lifesciences
MassDevice.com +3 | MDT looks to overturn $74M judgement in Edwards patent spat, Johnson & Johnson hit with FDA warning, MDUFA hearing set for mid-February
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
